Novel immunotherapy improves recovery from spinal cord injury
Scientists have developed an immunotherapy that protects neurons from immune cell attack at the site of traumatic spinal cord injury. …
Scientists have developed an immunotherapy that protects neurons from immune cell attack at the site of traumatic spinal cord injury. …
Mouse study addresses problem of immune system self-sabotaging antitumor immunotherapy. …
A newly developed antimicrobial compound effectively clears bacterial infections in mice, including those that can result in rare but potentially fatal “flesh-eating” illnesses. …
Research on hamsters indicates that nasal COVID-19 vaccines targeting the nose and mouth may be key to controlling the spread of respiratory infections. …
New study shows that brain inflammation caused by infections and neurodegenerative diseases releases interleukin-6, which travels from the brain to the muscles and leads to a loss of muscle function. …
A study in mice has shown that a strain of gut bacteria – Ruminococcus gnavus – can enhance the effects of cancer immunotherapy. …
Activation of immune cells called microglia with an antibody reduces amyloid plaques in the brain and mitigates behavioral abnormalities in mice with Alzheimer’s-like disease. …
Daily aspirin use is inexpensive and could reduce cardiovascular deaths globally, but fewer than half of people worldwide who have had a heart attack or stroke take the medication. …
A randomized controlled trial found that two commonly used anti-inflammatory drugs did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone. …
The gut microbiomes of people with pre-symptomatic Alzheimer’s disease have different composition than that of healthy individuals. …
End of content
End of content